Filing Details

Accession Number:
0001593968-21-001317
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-13 16:50:31
Reporting Period:
2021-05-11
Accepted Time:
2021-05-13 16:50:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887359 Vericel Corp VCEL Biological Products, (No Disgnostic Substances) (2836) 943096597
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1300997 K Paul Wotton C/O Vericel Corporation
64 Sidney Street
Cambridge MA 02139
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-11 17,500 $13.05 21,000 No 4 M Direct
Common Stock Acquisiton 2021-05-11 13,125 $14.56 34,125 No 4 M Direct
Common Stock Acquisiton 2021-05-11 13,125 $16.62 47,250 No 4 M Direct
Common Stock Disposition 2021-05-11 13,448 $50.11 33,802 No 4 S Direct
Common Stock Disposition 2021-05-12 2,200 $48.88 31,602 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-05-11 17,500 $0.00 17,500 $13.05
Common Stock Stock Option (right to buy) Disposition 2021-05-11 13,125 $0.00 13,125 $14.56
Common Stock Stock Option (right to buy) Disposition 2021-05-11 13,125 $0.00 13,125 $16.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2028-05-02 No 4 M Direct
0 2030-04-29 No 4 M Direct
0 2029-05-01 No 4 M Direct
Footnotes
  1. These options, representing the right to purchase a total of 17,500 shares, became exercisable in equal monthly installments over one year, beginning on May 2, 2018, contingent upon continued service to the Company.
  2. These options, representing the right to purchase a total of 13,125 shares, became exercisable in equal monthly installments over one year, beginning on April 29, 2020, contingent upon continued service to the Company.
  3. These options, representing the right to purchase a total of 13,125 shares, became exercisable in equal monthly installments over one year, beginning on May 1, 2019, contingent upon continued service to the Company.